Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)
Taiwan
· Delayed Price · Currency is TWD 64.40
+0.20 (0.31%)
May 14, 2025, 2:31 PM CST
Foresee Pharmaceuticals Revenue
Foresee Pharmaceuticals had revenue of 110.46M TWD in the quarter ending March 31, 2025, with 6.36% growth. This brings the company's revenue in the last twelve months to 425.30M, up 57.23% year-over-year. In the year 2024, Foresee Pharmaceuticals had annual revenue of 418.69M with 114.67% growth.
Revenue (ttm)
425.30M
Revenue Growth
+57.23%
P/S Ratio
23.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 418.69M | 223.65M | 114.67% |
| Dec 31, 2023 | 195.04M | -106.47M | -35.31% |
| Dec 31, 2022 | 301.51M | 75.48M | 33.39% |
| Dec 31, 2021 | 226.03M | -4.41M | -1.91% |
| Dec 31, 2020 | 230.44M | 155.24M | 206.44% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Pegavision | 6.69B |
| Lumosa Therapeutics | 43.59M |